BackContext Therapeutics Overview

Context Therapeutics Net Income

Profitability analysis for CNTX.

Quarterly Net Income

-$8.68M
89.65% YoY

As of Mar 2026

Annual Net Income (TTM)

-$40.23M
45.57% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...